Advent Technologies (https://www.advent.energy/), an innovative company in the sectors of fuel cells and hydrogen technology, announces its entry into the NASDAQ Stock Exchange in New York on February 5, 2021, following merger with AMCI Acquisition Corp.
European Research Project, coordinated by IMBB-FORTH, receives prestigious Horizon 2020 grant for the development of highly selective and safe insecticides
The group of Prof. John Vontas at IMBB-FORTH, in collaboration with the Agricultural University of Athens, several major European Research Institutes and Industrial partners and the University of Kentucky (USA), won an important grant, within the framework of the EU Horizon 2020 Programme.
Research by the teams of Prof. Athanasios Nenes and Spyros Pandis of the Center for Studies on Air Quality and Climate Change (C-STACC; http://cstacc.iceht.forth.gr) of the Institute of Chemical Engineering Sciences at the Foundation for Research and Technology-Hellas (ICE-HT/FORTH; http://www.iceht.forth.gr) led to the discovery of a chemical mechanism that rapidly produces air pollution from biomass burning, during the night.
Prof. Athanasios Nenes, Affiliated Scientist of FORTH/ICE-HT,Coordinating Member of the Center for the Study of Air Quality and Climate Change (C-STACC)  and Professor at the School of Architecture, Civil and Environmental Engineering, EPFL, Lausanne, Switzerland has been selected as a Highly Cited Researcher in the field of Geosciences (https://publons.com/researcher/4043389/athanasios-nenes/) by Web of Science (WoS). The methodology of this selection is based on the number of his publications and citations, those published and cited during 2009-2019, regarding the population of Researchers in the same field. It is also based on the number of highly cited papers that he has published (Source: Highly Cited Researchers Powered by Web of Science ). It is a great honor for Prof. Nenes, as WoS as a widely recognized and reliable platform for the evaluation of scientific work for every Researcher worldwide.
Professor Nektarios Tavernarakis elected Fellow of the American Association for the Advancement of Science
Nektarios Tavernarakis, Chairman of the Board of Directors at the Foundation for Research and Technology Hellas (FORTH) and Professor at the Medical School of the University of Crete, was elected Fellow of the American Association for the Advancement of Science (AAAS). This significant distinction comes as recognition of the scientific quality and the highly competitive research conducted at FORTH and the University of Crete. According to the Constitution of the prestigious AAAS, Fellowship is bestowed to scientists who have scientifically or socially distinguished themselves by efforts on behalf of the advancement of science, or its applications. Nominations for AAAS Fellows are evaluated for election by the Council of the Association. Nektarios Tavernarakis was honored for his distinguished contributions to the fields of ageing, neuroscience, mitochondrial biology, cell death and neurodegeneration.
As announced today in Brussels, Nektarios Tavernarakis, Chairman of the Board of Directors at the Foundation for Research and Technology – Hellas (FORTH), and Professor at the Medical School of the University of Crete, was unanimously elected Vice President of the European Research Council (ERC).
The medal Vilhelm Bjerknes 2021 is awarded to Prof. Spyros Pandis, a collaborating faculty member of the Institute of Chemical Engineering Sciences of FORTH
The European Geoscience Union (EGU) will award Prof. Spyros Pandis the medal Vilhelm Bjerknes for 2021. Prof. Pandis is a collaborating faculty member of FORTH/ICE-HT (Institute of Chemical Engineering Sciences) and professor at the Department of Chemical Engineering of the University of Patras. This medal is awarded for significant disciplinary contributions in the Earth, planetary and space sciences and the ceremony will be held during the EGU Annual Assembly, 25-30 April 2021.
New Spin-off Company founded by FORTH for the production of reflection-free glass that improves the quality of consumer electronics displays
A new spin-off company under the name “Biomimetic” was created leveraging patented technology developed at the Institute of Electronic Structure and Laser (IESL, www.iesl.forth.gr) of the Foundation for Research and Technology-Hellas (www.forth.gr). The company was founded by the Research Director Dr. Emmanuel Stratakis, together with FORTH research personnel Dr. Evangelos Skoulas, Mr. Andreas Lemonis, Mr. Antonis Papadopoulos and Mr. Alexandros Mimidis, as co-founders. The company raised 900.000€ seed funding by Big Pi Ventures (https://bigpi.vc/), one of the funds of EquiFund supported by the European Investment Fund (EIF). It is the second spin-off company of IESL that is financed by Big Pi within the last six months.
Novel method for COVID-19 diagnosis developed at FORTH receives funding for immediate market release
Biosensors lab of FORTH(http://biosensorslab.biology.uoc.gr/) has developed a novel molecular diagnostic method for the detection of nucleic acids at the point-of-care. The method exploits a newly designed portable 3D-printed device and a smartphone to perform isothermal amplification and real-time quantitative colorimetric detection of the target analyte. The simplicity of the methodology, rapid analysis time (<30 min) and affordable cost make it ideal for non-trained users at the point-of-need and in both the developed and resource limited countries. Clinical validation of the device with patients’ samples, for infectious diseases (COVID-19) and cancer-mutations (BRAF V600E) detection, demonstrated excellent performance compared to standard methods.
FORTH collaborating researcher’s major contribution to an important scientific publication in a leading medical journal, about a targeted treatment for Tumor-Induced Osteomalacia (TIO).
Dr Georgios Z. Papadakis, collaborating researcher of the Institute of Computer Science (ICS) of the Foundation for Research and Technology – Hellas (FORTH), had a major contribution on a study published on September 10th 2020, in the New England Journal of Medicine (NEJM), in collaboration with scientists from the National Institutes of Health (NIH) in Bethesda, Maryland, USA.
Page:123456789 | < Prev Next >